Trial
NCT03890120
Study of Cilofexor in Adults With Primary Sclerosing Cholangitis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Primary Sclerosing Cholangitis
Intervention
Cilofexor
Why stopped
Following recommendation of the external Data Monitoring Committee, after it reviewed the results of a planned interim futility analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-29